Zydus gets USFDA nod for Lamotrigine Extended-Release Tablets for seizures Medical Dialogues Bureau3 April 2020 1:32 PM ISTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Lamotrigine Extended-Release Tablets USP in the strengths of 25 mg, 50...
Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA Medical Dialogues Bureau2 April 2020 2:18 PM ISTNoida: Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a...
Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility Medical Dialogues Bureau1 April 2020 12:44 PM ISTBengaluru: Biocon Sdn Bhd, a subsidiary of Biocon Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S....
Lilly gets USFDA nod for Taltz(ixekizumab) for Pediatric Patients with Moderate to Severe Plaque Psoriasis Medical Dialogues Bureau1 April 2020 12:30 PM ISTIndianapolis: Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License...
Strides receives USFDA EIR for KRS Gardens, Bangalore facility Medical Dialogues Bureau31 March 2020 1:30 PM ISTBangalore: Strides Pharma Science Limited has announced that it has received the Establishment Inspection Report (EIR) for the inspection conducted by...
Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules Medical Dialogues Bureau31 March 2020 1:30 PM ISTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of...
South Korean coronavirus test kit makers win USFDA pre-approval Medical Dialogues Bureau30 March 2020 3:46 PM ISTSeoul: Three Korean coronavirus test-kit makers have won preliminary approval from the U.S. Food and Drug Administration (FDA), paving the way for...
Lupin gets USFDA EIR for Inhalation Research Center, Florida Medical Dialogues Bureau30 March 2020 3:04 PM ISTCoral Springs & Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S....
Sun Pharma: USFDA classifies Halol facility as Official Action Indicated Medical Dialogues Bureau30 March 2020 1:18 PM ISTMumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema Medical Dialogues Bureau29 March 2020 11:27 AM ISTAD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects
With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19 Medical Dialogues Bureau28 March 2020 12:09 PM ISTAbbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID...
Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients Medical Dialogues Bureau28 March 2020 10:15 AM ISTUS: Genentech, a member of the Roche Group has announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind,...
